Skip to content
value.today

Heart Test Laboratories, Inc.

🇺🇸 Colleyville, Texas, USATechnologyFounded 2007
Total raised
$12 M
3 rounds on record
Latest round
$6 M
Apr 2019
First round on record
Mar 2009
Today
Went public
See the company page

Heart Test Laboratories, Inc. is listed today as HeartSciences Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Heart Test Laboratories, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2023$1 MPrivate placement after listingUnder $2 million

Heart Test Laboratories, Inc.: Private sale, Nov 2023

Investors in this round

2 investors had bought by the notice of Dec 7, 2023: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Heart Test Laboratories, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Texas

People named in the notice

  • Andrew Simpson · Executive Officer, Director · Andrew Simpson is the President, Chief Executive Officer and Chairman of the Board of Directors.
  • Danielle Watson · Executive Officer · Danielle Watson is the Chief Financial Officer and Treasurer.
  • Mark Hilz · Executive Officer, Director · Mark Hilz is the Chief Operating Officer, Secretary and Director.
  • Brian R. Szymczak · Director
  • Bruce Bent · Director
  • David R. Wells · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Represents 3,125,000 shares of common stock issued to a noteholder to pay off $500,000 drawn from a note and 3,656,388 shares of common stock issued to a noteholder to pay off principal and interest under a loan agreement.”
  • On the use of proceeds: “Some proceeds to be used for general working capital purposes may include salaries, payments and expenses reimbursements to officers and/or directors listed above in Item 3.”

Signed by Andrew Simpson, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 7, 2023. Read the notice at the SEC.

equity, debt, optionsSEC
Sep 2023$1 MPrivate placement after listingUnder $2 million

Heart Test Laboratories, Inc.: Private sale, Sep 2023

Investors in this round

1 investor had bought by the notice of Sep 20, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Heart Test Laboratories, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Texas

People named in the notice

  • Andrew Simpson · Executive Officer, Director · Andrew Simpson is the President, Chief Executive Officer and Chairman of the Board of Directors
  • Danielle Watson · Executive Officer · Danielle Watson is the Chief Financial Officer and Treasurer.
  • Mark Hilz · Executive Officer, Director · Mark Hilz is the Chief Operating Officer, Secretary and Director.
  • Brian R. Szymczak · Director
  • Bruce Bent · Director
  • David R. Wells · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Represents the issuance of an unsecured promissory drawdown loan note of up to $1,000,000 and related issuance of up to 1,500,000 warrants, pursuant to the terms of such note and warrants.”
  • On the use of proceeds: “Some proceeds to be used for general working capital purposes may include salaries, payments and expenses reimbursements to officers and/or directors listed above in Item 3.”

Signed by Andrew Simpson, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 20, 2023. Read the notice at the SEC.

debt, optionsSEC
Apr 2019$6 MNo. 3$2 to $10 million

Heart Test Laboratories, Inc.: Raise no. 3, Apr 2019

Investors in this round

50 investors had bought by the notice of Dec 11, 2019: 50 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Heart Test Laboratories, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $7 M offered; $0 M still to sell
Smallest investment taken
$1,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$400,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Texas

People named in the notice

  • Andrew Simpson · Executive Officer
  • Mark Hilz · Executive Officer
  • Brian Szymczak · Director
  • John Adams · Director
  • John Owen · Director
  • Patrick Kanouff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Hilz, President/CEO. Source: SEC Form D, newest notice filed Dec 11, 2019. Read the notice at the SEC.

equitySEC
Dec 2014$4 MNo. 2$2 to $10 million

Heart Test Laboratories, Inc.: Raise no. 2, Dec 2014

Investors in this round

32 investors had bought by the notice of Jul 17, 2015: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Heart Test Laboratories, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $10 M offered; $6 M still to sell
Smallest investment taken
$5,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$70,000
Finders' fees
none
Paid to its own people
$300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Texas

People named in the notice

  • Mark Thomas Hilz · Executive Officer
  • Andrew Christopher Simpson · Director
  • Drew Christopher Diaz · Director
  • Kavy Christopher Jeffrey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Middlebury Securities (CRD 122602) · broker-dealer James Robinson (CRD 1651804) · Weyrbridge Rd, VermontSold in NY, PA, TX
  • Neidiger Tucker Bruner (CRD 7425) · broker-dealer Paul Davis (CRD 1630803) · Englewood, ColoradoSold in CO, TX

Remarks in the notice

  • On the amounts: “The offering closed in March. No further securities will be offered as part of this offering”
  • On the use of proceeds: “This is total estimated salaries for Mark Hilz and Andrew Simpson for the year 2015 at a rate of $150k per person.”

Signed by Mark T. Hilz, President/CEO. Source: SEC Form D, newest notice filed Jul 17, 2015. Read the notice at the SEC.

equity, optionsSEC
Mar 2009$2 MNo. 1Under $2 million

Heart Test Laboratories, Inc.: Raise no. 1, Mar 2009

Investors in this round

17 investors had bought by the notice of Jul 30, 2009: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Heart Test Laboratories, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$160,000
Finders' fees
none
Paid to its own people
$175,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Texas

People named in the notice

  • Drew Diaz · Executive Officer, Director, Promoter
  • Gary Chen · Executive Officer, Director, Promoter
  • Cheryl Yang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Niderger Tucker Bruner (CRD 7425) · Denver, CoSold in no state named

Remarks in the notice

  • On the use of proceeds: “Salary for the Issuer's officers from June 1009 through December 31, 2009”

Signed by Drew Diaz, Chief Excutive Officer. Source: SEC Form D, newest notice filed Jul 30, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Heart Test Laboratories, Inc. had revenue of up to $1 million when it filed its newest notice of a funding round (Dec 2023).

    SEC Form D (revenue range) · Dec 2023

  • Revenue range over time, as stated in its notices: no revenue in 2009; no revenue in 2015; revenue of up to $1 million in 2019; revenue of up to $1 million in 2023.

    SEC Form D (revenue range) · Dec 2023

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Dec 2023

Products and services#

No products or services of Heart Test Laboratories, Inc. are on record.

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in Heart Test Laboratories, Inc.
InvestorKindAmountRoundRoleSource
Andrew SimpsonPersonnot statednot statedHeld Series C preferred stock, director (Form 3, 2022)SEC Form 3
Brian SzymczakPersonnot statednot statedHeld Series C preferred stock, director (Form 3, 2022)SEC Form 3
Mark T. HilzPersonnot statednot statedHeld Series C preferred stock, director (Form 3, 2022)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 50 investors.

Largest shareholders today

Institutions holding HeartSciences Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Heart Test Laboratories, Inc.
NameRoleNamed in
Andrew SimpsonAndrew Simpson is the President, Chief Executive Officer and Chairman of the Board of Directors.Dec 2023
Danielle WatsonDanielle Watson is the Chief Financial Officer and Treasurer.Dec 2023
Mark HilzMark Hilz is the Chief Operating Officer, Secretary and Director.Dec 2023
Mark Thomas HilzExecutive officerJul 2015
Drew DiazExecutive officerJul 2009
Gary ChenExecutive officerJul 2009
Andrew SimpsonAndrew Simpson is the President, Chief Executive Officer and Chairman of the Board of Directors.Dec 2023
Brian R. SzymczakDirectorDec 2023
Bruce BentDirectorDec 2023
David R. WellsDirectorDec 2023
Mark HilzMark Hilz is the Chief Operating Officer, Secretary and Director.Dec 2023
Brian SzymczakDirectorDec 2019
John AdamsDirectorDec 2019
John OwenDirectorDec 2019
Patrick KanouffDirectorDec 2019
Andrew Christopher SimpsonDirectorJul 2015
Drew Christopher DiazDirectorJul 2015
Kavy Christopher JeffreyDirectorJul 2015
Cheryl YangDirectorJul 2009
Drew DiazDirectorJul 2009
Gary ChenDirectorJul 2009
Drew DiazPromoterJul 2009
Gary ChenPromoterJul 2009

Went public since 2022. Its SEC number is that of a company listed on a stock exchange.